US Patent Issued to Genfit on March 31 for "Compositions and methods for the treatment of primary biliary cholangitis" (French Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,086, issued on March 31, was assigned to Genfit (Loos, France).

"Compositions and methods for the treatment of primary biliary cholangitis" was invented by Pascal Birman (Paris), Alice Roudot (Lomme, France), David Magrez (Lambersart, France) and Benoit Noel (Gondecourt, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a pharmaceutical composition comprising elafibranor or a pharmaceutically acceptable salt thereof, for use to treat primary biliary cholangitis (PBC) in a subject intolerant to ursodeoxycholic acid (UDCA)."

The patent was filed on Aug. 25, 2021, under Application No. 18/017,591.

*For further informatio...